Literature DB >> 23674181

Current status of human papillomavirus vaccination implementation in central and eastern Europe.

Katja Seme1, Polona J Maver, Tina Korać, Amalia Canton, Jitka Částková, Goran Dimitrov, Irina Filippova, Helena Hudecová, Ermina Iljazović, Bernard Kaić, Vesna Kesić, Nerija Kuprevičienė, Dragan Laušević, Zsuzsanna Molnár, Jurijs Perevoščikovs, Marek Spaczyński, Venera Stefanova, Veronika Učakar, Mario Poljak.   

Abstract

We present a review of the current implementation status of vaccination against human papillomaviruses (HPV) and available data concerning the burden of HPV infection and HPV type-specific distribution in 16 central and eastern European countries: Albania, Bosnia and Herzegovina, Bulgaria, Croatia, the Czech Republic, Estonia, Montenegro, Poland, Romania, Serbia, Slovakia, Slovenia, and The Former Yugoslav Republic of Macedonia. At least one current HPV prophylactic vaccine is registered in all central and eastern European countries except Montenegro. Six counties-Bulgaria, the Czech Republic, Latvia, Romania, Slovenia, and Former Yugoslav Republic of Macedonia-have integrated the HPV vaccination into their national immunization program and currently provide routine vaccination free of charge to the primary target population. Ten countries have not integrated HPV vaccination into the national immunization program. The key reasons for lack of implementation of HPV vaccination into the national immunization program are the high vaccine cost and negative public perception. Vaccination of males is not recommended in any country in the region.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23674181

Source DB:  PubMed          Journal:  Acta Dermatovenerol Alp Pannonica Adriat        ISSN: 1318-4458


  6 in total

Review 1.  Eurogin Roadmap 2015: How has HPV knowledge changed our practice: Vaccines.

Authors:  Julia M L Brotherton; Mark Jit; Patti E Gravitt; Marc Brisson; Aimée R Kreimer; Sara I Pai; Carole Fakhry; Joseph Monsonego; Silvia Franceschi
Journal:  Int J Cancer       Date:  2016-03-22       Impact factor: 7.396

2.  Oral cancer knowledge and practice among medical students: A cross-sectional study during the Syrian crisis.

Authors:  Mhd Amin Alzabibi; Homam Alolabi; Dania Alsayed Ali; Mosa Shibani; Hlma Ismail; Fatema Mohsen; Humam Armashi; Bisher Sawaf; Sarya Swed; Aliaa Bakr; Louei Darjazini Nahas; Hazem S Ghaith; Karam R Motawea
Journal:  Ann Med Surg (Lond)       Date:  2022-04-11

3.  Cervical HPV type-specific pre-vaccination prevalence and age distribution in Croatia.

Authors:  Ivan Sabol; Nina Milutin Gašperov; Mihaela Matovina; Ksenija Božinović; Goran Grubišić; Ivan Fistonić; Dragan Belci; Laia Alemany; Sonja Džebro; Mara Dominis; Mario Šekerija; Sara Tous; Silvia de Sanjosé; Magdalena Grce
Journal:  PLoS One       Date:  2017-07-10       Impact factor: 3.240

4.  HPV-vaccination and cancer cervical screening in 53 WHO European Countries: An update on prevention programs according to income level.

Authors:  Emma Altobelli; Leonardo Rapacchietta; Valerio F Profeta; Roberto Fagnano
Journal:  Cancer Med       Date:  2019-04-16       Impact factor: 4.452

5.  Missed Opportunities for Human Papillomavirus Vaccination by Parental Nativity, Minnesota, 2015-2018.

Authors:  Emily A Groene; Keith J Horvath; Nicholas Yared; Inari Mohammed; Miriam Muscoplat; Sydney Kuramoto; Tyler Richter; Shalini Kulasingam
Journal:  Public Health Rep       Date:  2021-07-12       Impact factor: 3.117

6.  Factors that Predict Parental Willingness to Have Their Children Vaccinated against HPV in a Country with Low HPV Vaccination Coverage.

Authors:  Maria Ganczak; Barbara Owsianka; Marcin Korzeń
Journal:  Int J Environ Res Public Health       Date:  2018-03-31       Impact factor: 3.390

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.